Cover Image
市場調查報告書

全球體外診斷 (IVD) 市場

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 223486
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
Back to Top
全球體外診斷 (IVD) 市場 Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年10月06日 內容資訊: 英文 90 Pages
簡介

本報告提供全球體外診斷 (IVD) 市場發展趨勢分析,促進市場成長的要素與課題,各地區市場的主要趨勢,主要企業的市場佔有率/簡介等。

第1章 概要

  • IVD產品的種類
  • IVD檢驗
  • 各技術的IVD市場
  • IVD的利用
  • IVD的價值鏈分析

第2章 全球IVD市場

  • 收益
  • 收益預測
  • 各地區市場
  • 各產品類型市場
  • 各檢驗地區市場
  • 各技術市場

第3章 全球IVD市場:各技術

  • 血糖自我檢測 (SMBG) 市場收益預測
  • 臨床化學市場收益預測
  • 免疫化學市場
  • 分子診斷市場
  • 照護現場 (POC) 市場收益預測
  • 微生物學市場收益預測
  • 血液學市場收益預測

第4章 IVD的各地區市場

  • 北美
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 南美

第5章 市場動態

  • 成長推動因素
  • 主要趨勢
  • 課題

第6章 競爭情形

  • IVD市場佔有率
  • 免疫化學市場佔有率
  • 分子診斷市場佔有率
  • POCT市場佔有率
  • 臨床化學市場佔有率

第7章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient's body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

Growth of the global IVD market is driven by several factors including rapid occurrence of infectious diseases, increasing diabetic patient base, and surge in incidences of chronic ailments. Further, growing geriatric population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth prospects could be hindered by lack of customer adoption, lack of proper facilities and infrastructure and strict government regulations.

The report "Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.

Table of Contents

1. Overview

  • 1.1 In-Vitro Diagnostics (IVD)
  • 1.2 IVD Product by Types
  • 1.3 IVD Tests
  • 1.4 IVD Market by Technology
  • 1.5 IVD Uses
  • 1.6 IVD Value Chain Analysis

2. Global IVD Market

  • 2.1 Global IVD Market by Value
  • 2.2 Global IVD Market Forecast by Value
  • 2.3 Global IVD Market by Region
  • 2.4 Global IVD Market by Indications
  • 2.5 Global IVD Market by Test Location
  • 2.6 Global IVD Market by Product
    • 2.6.1 Global IVD Reagents Market Forecast by Value
    • 2.6.2 Global IVD Instrument Market Forecast by Value
  • 2.7 Global IVD Market by Technology

3. Global IVD Market Analysis by Technology

  • 3.1 Global SMBG Market Forecast by Value
  • 3.2 Global Clinical Chemistry Market Forecast by Value
  • 3.3 Global Immunochemistry Market
    • 3.3.1 Global Immunochemistry Market Forecast by Value
    • 3.3.2 Global Immunochemistry Market by Indications
  • 3.4 Global Molecular Diagnostics Market
    • 3.4.1 Global Molecular Diagnostics Market Forecast by Value
    • 3.4.2 Global Molecular Diagnostics Market by Indications
    • 3.4.3 Global Molecular Diagnostics Market by Regions
  • 3.5 Global Point Of Care (POC) Market Forecast by Value
  • 3.6 Global Microbiology Market
    • 3.6.1 Global Microbiology Market Forecast by Value
    • 3.6.2 Global Microbiology Market by Indication
  • 3.7 Global Hematology Market Forecast by Value

4. Regional IVD Market

  • 4.1 North America
    • 4.1.1 North America IVD Market Forecast by Value
    • 4.1.2 North America Microbiology Market by Indication
    • 4.1.3 The US IVD Market Forecast by Value
  • 4.2 EMEA
    • 4.2.1 EMEA IVD Market Forecast by Value
    • 4.2.2 Europe Microbiology Market by Indications
  • 4.3 Asia-Pacific
    • 4.3.1 Asia-Pacific IVD Market Forecast by Value
    • 4.3.2 China IVD Market Forecast by Value
    • 4.3.3 Japan IVD Market Forecast by Value
  • 4.4 Latin America
    • 4.4.1 Latin America IVD Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Diabetic Patient Base
    • 5.1.2 Rapid Occurrence of Infectious Diseases
    • 5.1.3 Surge in Incidences of Chronic Ailments
    • 5.1.4 Increasing Global Healthcare Expenditure Per Capita
    • 5.1.5 Rising Global GDP per Capita
    • 5.1.6 Growing Geriatric Population
  • 5.2 Key Trends & Developments
    • 5.2.1 Rise in CFDA IVD Market Approvals
    • 5.2.2 Consolidation of Core Labs
    • 5.2.3 Increasing Penetration of the US LDT Companies in European IVD Market
    • 5.2.4 Mergers & Acquisitions
  • 5.3 Challenges
    • 5.3.1 Lack of Customer Adoption
    • 5.3.2 Urgent Need for Proper Infrastructure
    • 5.3.3 Government Regulation for IVD Tests

6. Competitive Landscape

  • 6.1 Global IVD Market
    • 6.1.1 Revenue and Market Cap. Comparison
    • 6.1.2 Global IVD Market Share by Company
    • 6.1.3 Global Immunochemistry Market Share by Company
    • 6.1.4 Global Molecular Diagnostics Market Share by Company
    • 6.1.5 Global POCT Market Share by Company

7. Company Profiles

  • 7.1 Siemens AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Roche Holding AG
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Abbott Laboratories
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Danaher Corporation
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Figures

  • Types of Diagnostics
  • Types of IVD Products
  • Types of IVD Tests
  • IVD Market by Technology
  • IVD Value Chain Analysis
  • Global IVD Market by Value (2012-2016)
  • Global IVD Market Forecast by Value (2017-2021)
  • Global IVD Market by Region (2016)
  • Global IVD Market by Indications (2016)
  • Global IVD Market by Test Location (2016)
  • Global IVD Market by Product (2016)
  • Global IVD Reagents Market Forecast by Value (2016-2021)
  • Global IVD Instrument Market Forecast by Value (2016-2021)
  • Global IVD Market by Technology (2016)
  • Global SMBG Market Forecast by Value (2016-2021)
  • Global Clinical Chemistry Market Forecast by Value (2016-2021)
  • Global Immunochemistry Market Forecast by Value (2016-2021)
  • Global Immunochemistry Market by Indications (2016)
  • Global Molecular Diagnostics Market Forecast by Value (2016-2021)
  • Global Molecular Diagnostics Market by Indications (2016)
  • Global Molecular Diagnostics Market by Regions (2016)
  • Global Point Of Care (POC) Market Forecast by Value (2016-2021)
  • Global Microbiology Market Forecast by Value (2016-2021)
  • Global Microbiology Market by Indication (2016)
  • Global Hematology Market Forecast by Value (2016-2021)
  • North America IVD Market Forecast by Value (2016-2021)
  • North America Microbiology Market by Indication (2016)
  • The US IVD Market Forecast by Value (2016-2021)
  • EMEA IVD Market Forecast by Value (2016-2021)
  • Europe Microbiology Market by Indications (2016)
  • Asia-Pacific IVD Market Forecast by Value (2016-2021)
  • China IVD Market Forecast by Value (2016-2021)
  • Japan IVD Market Forecast by Value (2016-2021)
  • Latin America IVD Market Forecast by Value (2016-2021)
  • Global Type 2 Diabetes Patients Volume (2016-2021)
  • Global New Cancer Patients Volume (2012-2016)
  • Global Healthcare Expenditure Per Capita (2012-2016)
  • Global GDP Per Capita (2012-2016)
  • Global Population above 64 Years (2012-2016)
  • Global IVD Market Share by Company (2016)
  • Global Immunochemistry Market Share by Company (2016)
  • Global Molecular Diagnostics Market Share by Company (2016)
  • Global POCT Market Share by Company (2016)
  • Siemens AG Revenue by Segment (2016)
  • Siemens AG Revenue and Net Income (2012-2016*)
  • Siemens R&D Expenditure (2014-2016*)
  • Roche Holding AG Sales by Segment (2016)
  • Roche Holding AG Sales and Net Income (2012-2016)
  • Roche Holding AG R&D Expenditure (2014-2016)
  • Number of Products in Pipeline by Segments (2016)
  • Abbott Laboratories Sales by Segment (2016)
  • Abbott Laboratories Net Sales and Net Earnings (2012-2016)
  • Abbott Laboratories R&D Expenditure (2014-2016)
  • Danaher Corp. Revenue by Segments (2016)
  • Danaher Corp. Revenue and Net Earnings (2012-2016)
  • Danaher Corp. R&D Expenditure (2014-2016)

List of Charts

  • Growing Cases and Prevalence of STDs in the US (2012-2016)
  • Revenue and Market Cap. Comparison by Companies (2016)
Back to Top